Uzm. Dr. Hakan Taban

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma

Immunotherapy, 2026

DOI 10.1080/1750743x.2026.2722548 PMID 42683510 Frei zugänglicher VolltextQuelle: OpenAlex

Association of Cabazitaxel Treatment Beyond 10 Cycles with Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer: A Retrospective 8-Month Landmark Analysis

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15186966 PMID 42795739 Frei zugänglicher VolltextQuelle: ORCID

Clinical Characteristics and Survival Outcomes of a Clinically Defined Treatment-Emergent Neuroendocrine/Aggressive-Variant Prostate Cancer Phenotype: A Retrospective Study

Medicina, 2026

DOI 10.3390/medicina62091702 PMID 42796309 Frei zugänglicher VolltextQuelle: ORCID

Synchronous Adrenocortical Carcinoma, Renal Cell Carcinoma, and Mediastinal Mature Teratoma with Heterozygous Variants in SMARCA4, APC, and MYBP3: A Case Report

Journal of Oncological Sciences, 2026

DOI 10.37047/jos.galenos.2026.2025-10-7 Frei zugänglicher VolltextQuelle: ORCID

Prognostic Significance of SULF2 Expression in Surgically Resected Non-Small Cell Lung Cancer

Medical sciences (Basel, Switzerland), 2026

DOI 10.3390/medsci14020215 PMID 42201007 Frei zugänglicher VolltextQuelle: Europe PMC

Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program

Future Oncology, 2025

DOI 10.1080/14796694.2025.2570637 PMID 41103123 Frei zugänglicher VolltextQuelle: OpenAlex

Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel

Medicina, 2025

DOI 10.3390/medicina61061105 PMID 40572794 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach

Cancers, 2025

DOI 10.3390/cancers17020233 PMID 39858018 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

Evaluation of treatment regimens and prognostic factors in primary central nervous system lymphomas

Journal of Current Hematology & Oncology Research, 2025

DOI 10.51271/jchor-0062 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Prognostic value of the StAN score in elderly small cell lung cancer

Scientific Reports, 2025

DOI 10.1038/s41598-025-08115-x PMID 40604202 Frei zugänglicher VolltextQuelle: OpenAlex

The lactate dehydrogenase-to-albumin ratio is a prognostic biomarker in extensive-stage small-cell lung cancer

Acta Medica, 2025

DOI 10.32552/2025.actamedica.1159 Frei zugänglicher VolltextQuelle: OpenAlex

Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma

Journal of Chemotherapy, 2024

DOI 10.1080/1120009x.2024.2403051 PMID 39257075 2 Zitationen (Europe PMC) Quelle: OpenAlex

Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)

European Archives of Oto-Rhino-Laryngology, 2024

DOI 10.1007/s00405-024-08744-4 PMID 38795147 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).

Journal of Clinical Oncology, 2024

DOI 10.1200/jco.2024.42.16_suppl.e18004 Quelle: ORCID

Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving Chemotherapy

Cancers, 2024

DOI 10.3390/cancers16051061 PMID 38473418 9 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Challenges in using tumor mutational burden as a post-treatment biomarker

ESMO Open, 2024

DOI 10.1016/j.esmoop.2024.103999 PMID 39561622 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

1271P Integrating machine learning prediction and causal inference analysis to unravel determinants of progression in EGFR-mutant, advanced NSCLC

Annals of Oncology, 2024

DOI 10.1016/j.annonc.2024.08.1328 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Prognostic and predictive value of tumor infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer

Clinics and Research in Hepatology and Gastroenterology, 2023

DOI 10.1016/j.clinre.2023.102171 PMID 37352926 19 Zitationen (OpenAlex) Quelle: OpenAlex

The Prognostic Significance of KIAA1522 Expression in Non-Small-Cell Lung Cancer Patients

Cureus, 2023

DOI 10.7759/cureus.44016 PMID 37746394 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer

Clinics and Research in Hepatology and Gastroenterology, 2023

DOI 10.1016/j.clinre.2023.102091 PMID 36738855 Quelle: OpenAlex

Treatment selection for T4 laryngeal cancer: is organ-preserving approach possible with chemoradiotherapy or is multimodality treatment more effective?

Journal of Medicine and Palliative Care, 2023

DOI 10.47582/jompac.1314922 Frei zugänglicher VolltextQuelle: OpenAlex

Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience

South Asian Journal of Cancer, 2022

DOI 10.1055/s-0042-1755467 PMID 36756104 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Blood Based Biomarkers as Predictive Factors for Hyperprogressive Disease

Journal of Clinical Medicine, 2022

DOI 10.3390/jcm11175171 PMID 36079101 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report

Cureus, 2022

DOI 10.7759/cureus.27828 PMID 36106272 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Prognostic Factors Associated with Locally Advanced Gastric Cancer in Patients Treated with Adjuvant Chemotherapy

Journal of Oncological Sciences, 2022

DOI 10.37047/jos.2022-92230 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Nivolumab in Metastatic Renal Cell Carcinoma: Results from the Turkish Oncology Group Kidney Cancer Consortium Database

Future Oncology, 2021

DOI 10.2217/fon-2021-0717 PMID 34726480 7 Zitationen (Europe PMC) Quelle: OpenAlex

Nivolumab as second-line treatment and beyond for metastatic renal cell carcinoma: A real-life experience from Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.

Journal of Clinical Oncology, 2021

DOI 10.1200/jco.2021.39.6_suppl.321 1 Zitation (OpenAlex) Quelle: OpenAlex

Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinoma

Turkish journal of urology, 2021

DOI 10.5152/tud.2021.20377 PMID 33819441 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

Lower prognostic nutritional index is associated with poorer survival in patients receiving immune checkpoint inhibitors

Biomarkers in medicine, 2021

DOI 10.2217/bmm-2020-0674 PMID 34397271 8 Zitationen (Europe PMC) Quelle: Europe PMC

Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors

Supportive Care in Cancer, 2021

DOI 10.1007/s00520-020-05702-8 PMID 32851486 10 Zitationen (Europe PMC) Quelle: ORCID

PILE: a candidate prognostic score in cancer patients treated with immunotherapy

Clinical and Translational Oncology, 2021

DOI 10.1007/s12094-021-02560-6 PMID 33586122 24 Zitationen (Europe PMC) Quelle: ORCID

Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy

Supportive Care in Cancer, 2021

DOI 10.1007/s00520-021-06139-3 PMID 33709186 20 Zitationen (Europe PMC) Quelle: ORCID

456P Prognostic and predictive value of tumor-infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer

Annals of Oncology, 2021

DOI 10.1016/j.annonc.2021.08.977 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Adjuvant Treatment with Paclitaxel Plus Trastuzumab for Node-Negative Breast Cancer: Real-Life Experience

Future Oncology, 2021

DOI 10.2217/fon-2021-0303 PMID 34758639 4 Zitationen (OpenAlex) Quelle: OpenAlex

Adjuvant Capecitabine In Triple Negative Breast Cancer: The Earlier, The Better?

Journal of Oncology Pharmacy Practice, 2021

DOI 10.1177/10781552211045909 PMID 34628993 2 Zitationen (OpenAlex) Quelle: OpenAlex

İleri Evre Panreatiko Biliyer Sistem Tümörlerinde Tedavi

Turkiye Klinikleri Medical Oncology - Special Topics, 2021

Quelle: OpenAlex

Abstract PS10-52: Adjuvant treatment with paclitaxel plus trastuzumab for node negative human epidermal growth factor receptor 2-positive breast cancer: Real life experience

Cancer Research, 2021

DOI 10.1158/1538-7445.sabcs20-ps10-52 Quelle: OpenAlex

173P What to expect from NCCN BRCA testing criteria: A retrospective cohort analysis

Annals of Oncology, 2021

DOI 10.1016/j.annonc.2021.08.454 Frei zugänglicher VolltextQuelle: OpenAlex

Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)

Journal of Oncology Pharmacy Practice, 2020

DOI 10.1177/1078155219900908 PMID 32054412 9 Zitationen (Europe PMC) Quelle: OpenAlex

Development of de novo psoriasis during nivolumab therapy in a patient with small cell lung cancer

Journal of Oncology Pharmacy Practice, 2020

DOI 10.1177/1078155219877234 PMID 31566114 10 Zitationen (Europe PMC) Quelle: ORCID

CANCER EPIDEMIOLOGY IN ELDERLY PATIENTS

Turkiye Klinikleri eBooks, 2020

DOI 10.5336/978-625-401-191-7_p1 1 Zitation (OpenAlex) Quelle: OpenAlex

Evaluation of emergency department visits in patients treated with immune checkpoint inhibitors.

Journal of Clinical Oncology, 2020

DOI 10.1200/jco.2020.38.15_suppl.e24160 1 Zitation (OpenAlex) Quelle: OpenAlex

Defining the Optimal Regimen for Stage III Colon Cancer: Concerns with Study Design

Clinical Colorectal Cancer, 2020

DOI 10.1016/j.clcc.2020.02.011 PMID 32224043 Quelle: OpenAlex

1546P Prognostic role of tumoral DNA damage repair protein expression in patients with resectable pancreatic cancer

Annals of Oncology, 2020

DOI 10.1016/j.annonc.2020.08.2029 Frei zugänglicher VolltextQuelle: OpenAlex

1763P Daily chemotherapy and treatment unit in the COVID-19 era: Lessons of the first 60 days

Annals of Oncology, 2020

DOI 10.1016/j.annonc.2020.08.1827 Frei zugänglicher VolltextQuelle: OpenAlex

98P Low prognostic nutritional index is independently associated with poorer survival in patients receiving immune checkpoint inhibitors

Annals of Oncology, 2020

DOI 10.1016/j.annonc.2020.10.587 Frei zugänglicher VolltextQuelle: OpenAlex

Yaşlılarda Kanser Epidemiyolojisi

Turkiye Klinikleri Medical Oncology - Special Topics, 2020

Quelle: OpenAlex

The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer

Journal of Oncology Pharmacy Practice, 2019

DOI 10.1177/1078155219883004 PMID 31653193 17 Zitationen (Europe PMC) Quelle: OpenAlex

Clinical features and prognosis of patients with liposarcoma: Single-center experience.

Journal of Clinical Oncology, 2019

DOI 10.1200/jco.2019.37.15_suppl.e22557 Quelle: OpenAlex

Embedded outpatient palliative care service within the oncology clinic: Preliminary experience in Hacettepe Oncology Hospital

Annals of Oncology, 2019

DOI 10.1093/annonc/mdz261.017 Frei zugänglicher VolltextQuelle: OpenAlex